All products
GlyciHalt MV2 — Voglibose, Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets
Anti-DiabeticSchedule H & G

GlyciHalt MV2

Voglibose, Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets

Composition

  • Voglibose IP — 0.2 mg
  • Glimepiride IP — 2 mg
  • Metformin Hydrochloride IP — 500 mg (as sustained release form)
Dosage Form
Bilayered Tablet (Sustained Release)
Pack
10 x 10 Tablets
MRP
₹180.00 per 10 tablets (incl. all taxes)
Colour
Quinoline Yellow WS
Storage
Store protected from light and moisture, at a temperature not exceeding 30°C.

SCHEDULE H & G DRUG — WARNING: It is dangerous to take this preparation except under medical supervision. To be sold by retail on the prescription of a Registered Medical Practitioner only.

Marketed by

Stemgrow Pharmaceuticals

Manufactured by

Bioaltus Pharmaceuticals Pvt. Ltd.

19-20, DIC, Ind. Area, Baddi, Distt. Solan, (H.P.) 173205 — WHO-GMP Certified

Mfg. Lic. No. L/16/1795/MNB

Frequently asked questions

Product information for healthcare professionals, pharmacists and distributors.

What is the composition of GlyciHalt MV2?

Each bilayered tablet (sustained release) of GlyciHalt MV2 contains Voglibose IP — 0.2 mg; Glimepiride IP — 2 mg; Metformin Hydrochloride IP — 500 mg (as sustained release form).

Is GlyciHalt MV2 a prescription product?

GlyciHalt MV2 is a Schedule H & G drug. It is dangerous to take this preparation except under medical supervision, and it must be sold by retail only on the prescription of a Registered Medical Practitioner.

What pack size and MRP does GlyciHalt MV2 come in?

GlyciHalt MV2 is supplied as 10 x 10 Tablets. MRP: ₹180.00 per 10 tablets (incl. all taxes).

How should GlyciHalt MV2 be stored?

Store protected from light and moisture, at a temperature not exceeding 30°C. Keep out of reach of children.

Who manufactures and markets GlyciHalt MV2?

GlyciHalt MV2 is marketed by Stemgrow Pharmaceuticals and manufactured by Bioaltus Pharmaceuticals Pvt. Ltd., 19-20, DIC, Ind. Area, Baddi, Distt. Solan, (H.P.) 173205 — WHO-GMP Certified (Mfg. Lic. No. L/16/1795/MNB).

Which therapeutic category does GlyciHalt MV2 belong to?

GlyciHalt MV2 belongs to the Anti-Diabetic range from Stemgrow Pharmaceuticals — Voglibose, Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets.

Related products